Fewer stents vs usual stents for STEMI heart attack
Part of Heart & circulation clinical trials.
This study compares using fewer stents versus the usual number of stents during emergency angioplasty for a severe heart attack (STEMI). It aims to see if a less-is-more approach is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a type of heart attack called STEMI, where a major artery is completely blocked.
- You are scheduled for or have just had emergency angioplasty to open the blocked artery.
- You are not in cardiogenic shock (very low blood pressure).
- You do not have a non-heart disease that limits your life expectancy to less than 1 year.
- You are not allergic to aspirin, ticagrelor, prasugrel, clopidogrel, paclitaxel, or sirolimus.
- You have not had a prior coronary bypass surgery, chronic total blockages, or other complex heart conditions as listed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a specific stent (with no polymer coating) plus a single blood thinner plan with aspirin and another P2Y12 medicine is as safe and effective as the standard two-medicine plan after a STEMI heart attack. It may help people avoid longer exposure to stronger blood-thinning if the new approach works as well.
This study compares doing all heart artery procedures right away versus doing part of them later in people who had a heart attack and have blockage in more than one artery. It aims to see which approach is safer and works better after the initial emergency procedure.
This study compares two methods of placing a stent in a blocked heart artery after a recent heart attack. One method uses a special ultrasound called IVUS to guide placement, while the other uses standard X-ray imaging. The goal is to see which one leads to better recovery and fewer complications.
This trial compares a drug-coated balloon to a drug-coated stent for opening blocked arteries during a heart attack. It aims to see which device works better for patients having a specific type of heart attack called STEMI.
This study compares a lower dose of aspirin to the standard dose for people who had a heart attack and a stent placed. The goal is to see if the lower dose works just as well with fewer side effects.
This trial compares when to do a stent procedure (PCI) in people with NSTEMI who have disease in more than one coronary artery (non-IRA). It may help doctors choose the safest and most effective timing for treatment to improve outcomes.
Hear when a new ST Elevation Myocardial Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.